Embecta (EMBC) Cash & Equivalents (2022 - 2026)

Embecta has disclosed Cash & Equivalents across 5 years of filings, most recently posting $184.9 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $184.9 million, down 11.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $184.9 million (down 11.66% YoY), and the FY2025 annual result was $225.5 million, down 15.7% from the prior year.
• Cash & Equivalents came in at $184.9 million for Q1 2026 at Embecta, down from $201.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $385.2 million in Q4 2022 to a low of $184.9 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $275.1 million (2024), against an average of $274.4 million.
• Across the five-year window, Cash & Equivalents surged 31.06% in 2023 and slumped 30.19% in 2025, its largest moves.
• Embecta's Cash & Equivalents stood at $385.2 million in 2022, then slipped by 22.46% to $298.7 million in 2023, then declined by 29.7% to $210.0 million in 2024, then retreated by 4.14% to $201.3 million in 2025, then declined by 8.15% to $184.9 million in 2026.
• The last three Cash & Equivalents figures came in at $184.9 million (Q1 2026), $201.3 million (Q4 2025), and $225.5 million (Q3 2025), per Business Quant data.